hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06299449, orgStudyIdInfo id: KFSIRB200-174, briefTitle: Artificial Intelligence Assisted Socket Shield With Computer Guided Implant Placement, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-05, primaryCompletionDateStruct date: 2025-03-15, completionDateStruct date: 2025-03-20, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Kafrelsheikh University, class: OTHER, descriptionModule briefSummary: Aim of the current randomized clinical trial is to evaluate and compare the effectiveness of computer-guided immediate implant placement performed simultaneously with artificial intelligence assisted socket shield technique versus conventional approach., conditionsModule conditions: Implant Complication, conditions: Dental Implant Failed, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 46, type: ESTIMATED, armsInterventionsModule interventions name: free-hand socket shield, interventions name: AI/guided socket shield, outcomesModule primaryOutcomes measure: Stability Quotient of dental implant, primaryOutcomes measure: pink esthetic score, primaryOutcomes measure: Midfacial Mucosal Alterations, primaryOutcomes measure: facial marginal bone level, eligibilityModule sex: ALL, minimumAge: 19 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: faculty of dentistry, kafrelsheikh University, status: RECRUITING, city: Kafr Ash Shaykh, state: Kafrelsheikh, zip: 214312, country: Egypt, contacts name: walid elamrousy, role: CONTACT, phone: +201005724781, email: Waled_Hammed@den.kfs.edu.eg, geoPoint lat: 31.11174, lon: 30.93991, hasResults: False
protocolSection identificationModule nctId: NCT06299436, orgStudyIdInfo id: IRB00426760, secondaryIdInfos id: R01HL172830, type: OTHER, domain: NHLBI/NIH, briefTitle: Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure, acronym: HALT-RHF, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2029-03-31, completionDateStruct date: 2029-03-31, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Johns Hopkins University, class: OTHER, collaborators name: National Heart, Lung, and Blood Institute (NHLBI), descriptionModule briefSummary: Right ventricular (RV) failure is recognized to worsen patient outcomes in the setting of heart failure with reduced ejection fraction (HFrEF)-related pulmonary hypertension (PH), yet the investigators fall short in trying to identify and treat it. The current proposal will (1) determine the best clinical indicators of intrinsic RV myocyte contractile failure in humans with HFrEF-PH, (2) clarify underlying mechanisms, and (3) test novel treatments on RV myocytes. The long-term goal of this proposal will be to better identify and treat RV failure in humans suffering from HFrEF-PH., conditionsModule conditions: Heart Failure With Reduced Ejection Fraction, conditions: Pulmonary Hypertension, conditions: Right Heart Failure Due to Left Heart Failure, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 50, type: ESTIMATED, outcomesModule primaryOutcomes measure: Diagnostic accuracy based on Area Under Curve (AUC), secondaryOutcomes measure: Percentage improvement in ex vivo right ventricular tissue sample, secondaryOutcomes measure: Predictive capacity (based on likelihood ratio), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 90 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06299423, orgStudyIdInfo id: 3677, briefTitle: Perioperative Monitoring to Assess Preoperative Anxiety in Inflammatory Bowel Disease Patients, acronym: PeRseo, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-22, primaryCompletionDateStruct date: 2025-06-30, completionDateStruct date: 2025-11-30, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-08, sponsorCollaboratorsModule leadSponsor name: Istituto Clinico Humanitas, class: OTHER, descriptionModule briefSummary: Anxiety and depression are extremely common among Inflammatory Bowel Disease (IBD) patients undergoing surgery and may increase the risk of postoperative adverse outcomes. This study aims to objectively evaluate preoperative psychological distress by remotely measuring the patient's physiological parameters and Heart Rate Variability (HRV) with the Howdy Senior ® device (Comftech Srl). Additionally, the study will also investigate the feasibility and effectiveness of the Howdy Senior® device in improving the postoperative patient's monitoring., conditionsModule conditions: Inflammatory Bowel Diseases, conditions: Surgery, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: SEQUENTIAL, interventionModelDescription: Single-center, interventional, case-series study with a historical cohort of comparison, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Howdy Senior® device, outcomesModule primaryOutcomes measure: Correlation between preoperative anxiety and preoperative Heart Rate Variability (HRV), secondaryOutcomes measure: Correlation between preoperative anxiety and 90-day Comprehensive Complication Index (CCI), secondaryOutcomes measure: Correlation between preoperative anxiety and preoperative Patient Health Engagement Scale (PHE-S), secondaryOutcomes measure: Correlation between preoperative anxiety and C-Reactive Protein (CRP) level 24 hour after surgery, secondaryOutcomes measure: 90-day postoperative complications, secondaryOutcomes measure: Correlation between the 90-day Postoperative Recovery Profile (PRP) and 90-day Heart Rate Variability (HRV), secondaryOutcomes measure: Healthcare costs, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: IRCCS Humanitas Research Hospital, status: RECRUITING, city: Rozzano, state: MI, zip: 20089, country: Italy, contacts name: Annalisa Maroli, PhD, role: CONTACT, phone: 02 8224 7776, phoneExt: 0039, email: colorapp@humanitas.it, geoPoint lat: 45.38193, lon: 9.1559, hasResults: False
protocolSection identificationModule nctId: NCT06299410, orgStudyIdInfo id: ITI-1284-008, briefTitle: PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-03, completionDateStruct date: 2025-03, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Intra-Cellular Therapies, Inc., class: INDUSTRY, descriptionModule briefSummary: The study will be conducted as an open-label and single-center study to evaluate the occupancy of ITI-1284 to the dopamine D2 receptor in healthy subjects. Subjects will enroll in one of the 2 cohorts, will have a baseline PET/CT scan, will receive a single dose of ITI-1284, and undergo one postdose PET/CT scan., conditionsModule conditions: Healthy Volunteers, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 12, type: ESTIMATED, armsInterventionsModule interventions name: ITI-1284 10 mg, interventions name: ITI-1284 20 mg, outcomesModule primaryOutcomes measure: % Receptor occupancy, secondaryOutcomes measure: Pharmacokinetics: AUC0-t, secondaryOutcomes measure: Pharmacokinetics: Cmax, secondaryOutcomes measure: Pharmacokinetics: Tmax, secondaryOutcomes measure: Percentage of subjects with treatment-emergent adverse events, secondaryOutcomes measure: Change from baseline in ECG QT interval, secondaryOutcomes measure: Change from baseline in aspartate aminotransferase, secondaryOutcomes measure: Change from baseline in alanine aminotransferase, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Clinical Site 1, city: New Haven, state: Connecticut, zip: 06520, country: United States, geoPoint lat: 41.30815, lon: -72.92816, hasResults: False
protocolSection identificationModule nctId: NCT06299384, orgStudyIdInfo id: R44MH133517, type: NIH, link: https://reporter.nih.gov/quickSearch/R44MH133517, briefTitle: The Use of Voice-Based AI in 988 Crisis Counseling, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2026-06, completionDateStruct date: 2026-08, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Lyssn.io, Inc., class: INDUSTRY, collaborators name: ProtoCall Services, Inc., descriptionModule briefSummary: Effective training requires repeated opportunities for skills practice with performance-based feedback, which is challenging to provide at scale. This research study focuses on developing an AI-based, coding and feedback tool ("LyssnCrisis") for implementation in a nationally utilized crisis call center, training counselors (call-takers) in suicide risk assessment skills, and evaluating LyssnCrisis to improve services and client outcomes. Our goal is to maximize the human capacity of call-takers to help assess their callers for risk of suicidality, and thus, a core aspect of the current research is developing a novel training process that supports human call-taker capacities., conditionsModule conditions: Suicide, conditions: Suicide and Self-harm, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: LyssnCrisis, outcomesModule primaryOutcomes measure: Post-Call Survey, primaryOutcomes measure: Call-taker crisis counseling fidelity, primaryOutcomes measure: System Usability Scale (SUS), primaryOutcomes measure: Acceptability of Intervention Measure; AIM, primaryOutcomes measure: Intervention Appropriateness Measure; IAM, primaryOutcomes measure: Feasibility of Intervention Measure; FIM, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06299371, orgStudyIdInfo id: MA-NSCLC-II-033, briefTitle: Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-15, primaryCompletionDateStruct date: 2026-04-15, completionDateStruct date: 2029-04-15, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Liaoning Tumor Hospital & Institute, class: OTHER, descriptionModule briefSummary: This is a prospective, single-arm study to investigate the efficacy and safety of Adebrelimab in combination with paclitaxel for injection (albumin bound) and platinum chemotherapy as neoadjuvant therapy in resectable non-small cell lung cancer harboring driver gene mutations, conditionsModule conditions: Non Small Cell Lung Cancer, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 36, type: ESTIMATED, armsInterventionsModule interventions name: Adebrelimab, interventions name: paclitaxel for injection (albumin bound), interventions name: Cisplatin or Carboplatin, outcomesModule primaryOutcomes measure: Pathological complete response rate, secondaryOutcomes measure: Major pathologic response rate, secondaryOutcomes measure: R0 rate, secondaryOutcomes measure: Event Free Survival, secondaryOutcomes measure: Overall Survival, secondaryOutcomes measure: Objective response rate, secondaryOutcomes measure: Adverse Events, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06299345, orgStudyIdInfo id: 1870394-1, briefTitle: The Effect of Motor Imagery Dosage on Motor Learning in Healthy Adults, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-03-01, primaryCompletionDateStruct date: 2022-04-20, completionDateStruct date: 2022-04-28, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-12, sponsorCollaboratorsModule leadSponsor name: Ahmed Mahmoud Kadry, class: OTHER, collaborators name: Concordia University Wisconsin, descriptionModule briefSummary: The goal of this clinical trial is to compare the effects of different durations of Motor Imagery (MI) practice and physical practice on motor performance enhancement in healthy adults. The main questions it aims to answer are:* Does Motor Imagery (MI) practice improve motor performance?* How do different doses of MI practice (low vs. high) compare to no MI practice in enhancing motor performance?Participants:* Be randomly assigned to one of three groups: no MI practice (control group), low dose MI practice (6 minutes per session), or high dose MI practice (12 minutes per session).* Complete nine sessions over three weeks, practicing a timed mirror tracing task.* Have their performance measured in each session by the time taken to complete the task and the number of errors made.Compared the control group, low dose MI group, and high dose MI group to see if there are significant differences in motor performance enhancement, aiming to determine the effectiveness of MI and the optimal dose for practice., conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: SINGLE, maskingDescription: The participants were blinded about which group they were allocated (control or intervention), whoMasked: PARTICIPANT, enrollmentInfo count: 27, type: ACTUAL, armsInterventionsModule interventions name: Motor imagery training, interventions name: NO motor imagery training, outcomesModule primaryOutcomes measure: Time, primaryOutcomes measure: Errors, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule locations facility: Concordia University Wisconsin, city: Mequon, state: Wisconsin, zip: 53097, country: United States, geoPoint lat: 43.21573, lon: -88.02962, locations facility: Kafrelshaikh University, city: Kafr Ash Shaykh, zip: 12623, country: Egypt, geoPoint lat: 31.11174, lon: 30.93991, hasResults: False
protocolSection identificationModule nctId: NCT06299332, orgStudyIdInfo id: DO611503A, briefTitle: Safety and Efficacy of Bi-Polar Radiofrequency for the Treatment of Erectile Dysfunction, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-06-23, primaryCompletionDateStruct date: 2024-05, completionDateStruct date: 2025-05, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: InMode MD Ltd., class: INDUSTRY, descriptionModule briefSummary: The goal of this prospective pilot study is to learn about the Safety and Efficacy of Radiofrequency (RF) for the Treatment of Erectile Dysfunction. This research study is trying to determine if RF therapy is safe and effective in patients with symptoms of erectile dysfunction (ED)., conditionsModule conditions: Erectile Dysfunction, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Prospective, open-label clinical study., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Device treatment, outcomesModule primaryOutcomes measure: Change in ED symptoms, following the RF treatment, secondaryOutcomes measure: Change in sexual activity leading to optimal penetration, secondaryOutcomes measure: Evaluate efficacy of the RF treatment for erectile function, secondaryOutcomes measure: Evaluate efficacy of the RF treatment for erectile function, secondaryOutcomes measure: Evaluate efficacy of the RF treatment for erectile function, secondaryOutcomes measure: Evaluate efficacy of the RF treatment for hardness of erection, otherOutcomes measure: Measuring pain level during the procedure, eligibilityModule sex: MALE, minimumAge: 40 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: LC Medical 140 W 58th St, Suite A New York, NY 10019, status: RECRUITING, city: New York, state: New York, zip: 10019, country: United States, contacts name: Lanna Cheuck, role: CONTACT, phone: 929-492-2052, geoPoint lat: 40.71427, lon: -74.00597, locations facility: Washington Heights Urology, status: RECRUITING, city: New York, state: New York, zip: 10032, country: United States, contacts name: Robert Valenzuela, role: CONTACT, phone: 212-781-9696, geoPoint lat: 40.71427, lon: -74.00597, hasResults: False
protocolSection identificationModule nctId: NCT06299293, orgStudyIdInfo id: 21C306, briefTitle: Facial Emotion Recognition in Anorexia Nervosa, acronym: FER_AN, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-02-01, primaryCompletionDateStruct date: 2024-02-01, completionDateStruct date: 2024-02-01, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Istituto Auxologico Italiano, class: OTHER, descriptionModule briefSummary: Altered emotional processing is reported in Anorexia Nervosa. However, this capability is generally measured through explicit measures, like self-report questionnaires and facial emotion recognition tasks. Instead, no previous research has investigated implicit emotional processing in this clinical condition. In the implicit facial emotion recognition task grounded on the implicit "redundant target effect", individuals generally respond faster when two identical targets are presented simultaneously rather than when presented alone; moreover, the competitive presence of a distractor (that is another emotion or a neutral expression) affects the correct recognition of the target. The ability to recognize and detect facial expressions is explored about two main emotions, fear and anger, because of their role in the intra- and interindividual psychological processing., conditionsModule conditions: Anorexia Nervosa, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 40, type: ACTUAL, armsInterventionsModule interventions name: Facial Emotion Recognition Test, outcomesModule primaryOutcomes measure: Behavioural measure relative to recognition ability, secondaryOutcomes measure: Behavioural measure relative to the detection ability, eligibilityModule sex: FEMALE, minimumAge: 20 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: IRCCS Istituto Auxologico Italiano - Ospedale San Giuseppe, city: Piancavallo, state: VCO, zip: 28824, country: Italy, hasResults: False
protocolSection identificationModule nctId: NCT06299267, orgStudyIdInfo id: Igdir181, briefTitle: The Effect of Dual Task on Manual Skill Performance in Children and Adolescents, acronym: Dual-task, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2024-06-15, completionDateStruct date: 2024-07-15, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Igdir University, class: OTHER, descriptionModule briefSummary: The aim of the study is to investigate the effect of dual-task conditions on manual dexterity performance in typically developing young people and children between the ages of 7-18.MATERIAL AND METHOD:* Demographic information, dominant extremity will be noted and the evaluation will begin by applying the Physical Activity Questionnaire for Children.* The evaluations will primarily evaluate the child's performance on a single cognitive task* The cognitive task will be the n-back task (counting down task) to be applied in accordance with the level of the child or adolescent.* Using the Visual Analogue Scale (VAS), participants will be asked to score the difficulty of the cognitive task as a number between 0 and 10.* the 9-Hole Test will be applied and the times will be recorded by asking to write a given paragraph.* Dual task evaluations will be administered by giving a simultaneous cognitive task while administering the -9-Hole Test and writing a paragraph.* In order to reveal the dual-task cost (DTC), dual-task performance will be subtracted from single-task performance and the difference will be calculated in seconds.As a result of this study, manual dexterity performance and cognitive performance in single-task conditions in typically developing children and adolescents will be revealed. Additionally, changes in this performance will be detected in dual-task situations., conditionsModule conditions: Child, Only, conditions: Adolescent Development, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: SCREENING, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: dual task conditions, outcomesModule primaryOutcomes measure: single cognitive task, primaryOutcomes measure: Visual Analogue Scale (VAS), primaryOutcomes measure: 9-Hole Peg Test.-Single task, primaryOutcomes measure: 9-Hole Peg Test and writing a given paragraph.-Dual task, primaryOutcomes measure: writing a given paragraph.-Single task, primaryOutcomes measure: writing a given paragraph.-Dual task, eligibilityModule sex: ALL, minimumAge: 7 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule, hasResults: False